MedTrace Logo

Mesenchymal Stem Cells; Donor and Role in Management and Reconstruction of Nonunion Fracture

NCT01626625 · Status: UNKNOWN · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 10

Last updated 2012-06-25

No results posted yet for this study

Summary

The investigators hypothesized that mesenchymal stem cells can be isolated from fracture site, iliac crest, and tibial crest, and can be expanded to be used in the management of nonunion fracture.

Conditions

  • Healing of Fracture

Interventions

DRUG

stem cells + hydroxy apatite

patient will be transplanted with stem cells and hydroxyapatite

OTHER

autograft taken from iliac crest

patient will be transplanted with autograft

Sponsors & Collaborators

  • Indonesia University

    lead OTHER

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-04-30
Primary Completion
2015-04-30
Completion
2016-01-31

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01626625 on ClinicalTrials.gov